COMP <GO>
AUUD vs HCTI // PIOTROSKI F-SCORE QUALITY
Auddia Inc. (NASDAQ) VS. Healthcare Triangle Inc. (NASDAQ) • 15-METRIC TALLY: AUUD 1
— HCTI 1
■ METRIC PARITY
LAST: $0.84 (+0.32%) • MKT CAP: $4.9M
piotroski-score
3/9
LAST: $6.30 (-2.02%) • MKT CAP: $5.6M
piotroski-score
3/9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AUUD VS. HCTI)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | AUUD | HCTI | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 96.00% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | -60.00% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | -60.00% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | 18.80% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 0.20 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality ACTIVE | 3/9 | 3/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 33.4 | 24.9 | +8.50 | AUUD | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $4.9M | $5.6M | -$684.3K | HCTI | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | AUUD REV | HCTI REV | AUUD GROSS % | HCTI GROSS % | AUUD FCF | HCTI FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $13.9M | — | 98.0% | -$5.6M | -$16.5M |
| FY 2024 | $0 | $11.7M | — | 98.0% | -$5.1M | -$1.1M |
| FY 2023 | $0 | $33.2M | — | — | -$4.5M | -$2.2M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AUUD // BETA —
HCTI // BETA —